Objectives: To investigate the effect of subinhibitory concentrations of cell wall active antibiotics on virulence gene expression and biofilm formation in Staphylococcus aureus Newman and in laboratory strains.
Introduction
Staphylococcus aureus is a Gram-positive pathogen that causes community-acquired and nosocomial infections ranging from carbuncles and food poisoning to acute endocarditis and necrotizing pneumonia. 1, 2 During antimicrobial therapy bacteria may be exposed to sub-MICs of antibiotics. 3 Low doses of antimicrobial compounds modulate expression of genes encoding factors essential for housekeeping and metabolic functions, and also those necessary to establish an infection. 4 -6 Some 60 years ago, S. aureus was susceptible to all antibiotics, but in the intervening years strains of this pathogen (like others) have developed resistance to almost every available antimicrobial agent. Repeated chemical modification of active compounds, most particularly the b-lactam class, have provided derivatives effective in the short term, but the pathogen has rapidly evolved new resistance mechanisms with each new introduction. This may be due in part to the mutagenesis-stimulating activity of sub-MIC antibiotics; such exposure also enhances virulence gene expression and concomitant aggravation of disease caused by S. aureus. 6 Here, we report studies examining the effects of low concentrations of antimicrobial compounds on virulence gene expression in S. aureus.
S. aureus virulence is multifactorial, involving the production of a variety of cell-bound and secreted proteins as well as the formation of biofilms. These processes are under the control of global regulators, especially the accessory gene regulon (Agr). 2 Agr is a two-component signal transduction quorum-sensing system that acts, at increased bacterial cell densities, to produce a regulatory RNA molecule (RNAIII), which in turn inhibits expression of cell wall associated proteins and facilitates the production of exotoxins (Figure 1) . 7 Staphylococcal protein A (Spa), a cell wall anchored protein, prevents opsonophagocytosis and interacts with von Willebrand factor, mediating intravascular infection. 8 -10 Production of Spa is down-regulated by RNAIII through inhibition of SarS, a DNA-binding protein that normally activates transcription of spa. 12,13 S. aureus has the ability to form small colony variants that produce decreased amounts of exotoxins, thus avoiding detection by the immune system.
14 Such variants are deficient in electron transport, a property that makes them resistant to aminoglycosides and allows them to persist inside the cell; they are believed to be one of the sources of recurrent staphylococcal infections. 15 Staphylococcal cell wall functions are the major targets for antimicrobial therapy. In this study we investigated transcription modulation of spa, lukE and agr RNAIII in the presence of sub-MICs of a number of cell wall active antibiotics using the promoter -reporter fusions spa-lux, lukE-lux and agrP3-lux, respectively, in S. aureus hosts Newman, 8325-4, RN4220, ALC488 and ALC1927. We examined combinations of antimicrobials that might influence the production of virulence factors during antibiotic therapy and investigated the effects of antibiotics on biofilm formation in S. aureus Newman on its hemB-deficient mutant, which mimics the small colony variant phenotype, and also a spa-deficient mutant.
Materials and methods
Strains, plasmids and growth conditions used in this study S. aureus strains and E. coli DH10B were grown at 378C in NYE [1% casein hydrolysate (Sigma), 0.5% yeast extract (Difco) and 0.5% NaCl (Fisher Scientific)] and Luria-Bertani (LB) [1% tryptone (Difco), 0.5% yeast extract (Difco) and 0.5% NaCl (Fisher Scientific)] media, respectively. S. aureus hosts for promoter-lux reporter fusions are listed in Table 1 . Antibiotics were obtained from Sigma and antibiotic discs from Becton Dickinson (BD) and Difco.
Construction of plasmids carrying the promoter-lux reporter fusions
The nucleotide sequences for agrP3 and lukE were retrieved from the S. aureus NCTC 8325 genome database and oligonucleotide primers were prepared (Integrated DNA Technologies) to amplify selected promoters of interest (Table 2) . PCR conditions were as follows: 948C for 5 min (initial denaturation); 35 cycles at 948C for 30 s, 608C for 30 s, 728C for 45 s; and 728C for 5 min. The PCR products were digested with BamHI (New England Biolabs) and ligated into BamHI-digested and phosphatase-treated pAmilux 16 using T4 DNA ligase (New England Biolabs). The ligation mix was transformed into E. coli DH10B and transformants selected on LB agar supplemented with 100 mg/L of ampicillin. The insert orientation was confirmed by sequencing using primers as shown in Table 2 and plasmid DNA, isolated from E. coli DH10B and S. aureus RN4220, was transformed into S. aureus RN4220 and other S. aureus strains, respectively, using standard procedures. 17 The S. aureus transformants were selected on NYE supplemented with 10 mg/L of chloramphenicol (NYEC).
Disc diffusion assay
A single colony of S. aureus on NYEC agar was resuspended in 50 mL sterile water and samples were mixed with 7 mL of 0.7% agar and poured as overlays on NYEC agar plates. Paper discs containing antibiotics were placed on the overlay and the plates were incubated at 378C. Subrt et al.
The antibiotics used in this study were 10 mg cloxacillin (Sigma), 10 mg bacitracin (BD), 5 mg methicillin (BD), 0.15 mg penicillin G (BD), 0.75 mg nafcillin (Sigma), 0.75 mg oxacillin (Sigma), 0.5 mg imipenem (Sigma), 30 mg vancomycin (BD), 2.5 mg cefoperazone (Sigma), 1.5 mg cefalotin (Sigma) and 30 mg daptomycin (BD). After 20 h, inhibition zones were measured and luminescence responses were detected using a Luminograph LB980 camera (Berthold). Representative results from at least three independent experiments are presented.
Quantification analysis of transcription
The effects of sub-MIC antibiotics on transcription modulation were also assessed using quantitative reverse transcriptase PCR (qRT-PCR). S. aureus Newman cells carrying a promoter-lux reporter construct were spread on NYEC and single antibiotic discs placed in the centre of the Petri plates and incubated at 378C for 16 to 18 h. The bacteria immediately outside of the zone of inhibition were carefully removed with a spatula and placed in RNAProtect bacteria reagent solution (Qiagen). For the negative control, cells were taken from the edge of the plate. RNA purification was done using a Qiagen RNeasy mini prep kit. qRT-PCR primers are listed in Table 2 . qRT-PCR was carried out in 96-well microtitre PCR plates (Sarstedt) as follows: 30 min at 428C for reverse transcription; denaturation at 948C for 2 min; 40 cycles at 948C for 15 s, 608C for 15 s and 608C for 15 s; to obtain dissociation curves the samples were held at 948C for 1 min, 608C for 30 s and 948C for 30 s. The housekeeping gene encoding pyruvate kinase (pyk) was used for normalization. Expression of luxA was used as a positive control to confirm that light production corresponded to promoter activation, and agrB was used as a negative control. Each experiment was done in duplicate with a minimum of four samples for each target gene. The relative standard curve method was used to quantify transcription.
Biofilm assay
The procedure was carried out as previously described. 18 Overnight cultures of S. aureus were adjusted to OD 600 3.0 and diluted 200-fold into fresh Tryptic Soy Broth (BD) medium supplemented with 0.25% glucose. Antibiotic solution (10 mL) or sterile water (10 mL) was added into wells of a 96-well round-bottom polystyrene plate (Sarstedt) and diluted culture (190 mL) was dispensed into each well and incubated for 24 h at 378C. Planktonic cells were decanted and the biofilm remaining in each well was washed three times with 300 mL of water and stained with 200 mL of 0.1% safranin for 30 s (Fisher Scientific). The safranin was washed out and the plates were allowed to dry at room temperature for several hours. The density of the biofilm in each well was determined by dissolving the stain in 300 mL of 100% ethanol for 30 min and the absorbance was measured at 490 nm using a SpectraMax 190 microplate spectrophotometer (Molecular Devices).
Results and discussion
b-lactam antibiotics are the drugs of choice for treating staphylococcal infections, either alone or in combination with other antimicrobial agents. We investigated the ability of cell wall active compounds to modulate the transcription of spa, lukE and agr RNAIII in S. aureus. A selection of strains carrying promoter-lux reporter constructs was employed to monitor changes in transcription and qRT-PCR was used to confirm the results.
Antibiotics differentially modulate the transcription of S. aureus genes
It has been shown previously that sub-MIC antibiotics enhance virulence in staphylococcal infections. 6 We found that expression of spa and lukE was strongly stimulated by sub-MICs of penicillin and cefalotin in S. aureus Newman, suggesting that such compounds may enhance bacterial pathogenesis (Figure 2a) . Induction levels varied between closely related antibiotics of the same class (cloxacillin and oxacillin; cefalotin and cefoperazone) (Figure 2a ). Cloxacillin and oxacillin differ only in a chlorine substitution on the aromatic ring, while cefalotin and cefoperazone are group I and II cephalosporins, respectively. The variations in stimulatory effects within these b-lactams suggest that the transcriptional differences we observed may reflect subtle alterations in the interaction of the inhibitors with their cellular targets, such as altering binding efficiency. qRT-PCR was used to confirm that modulation of gene expression in S. aureus Newman took place at the transcription level in cultures exposed to sub-MICs of active antibiotics. Expression of spa was examined when cells were exposed to sub-MICs of nafcillin, cefalotin or vancomycin (see Table S1 available as Supplementary data at JAC Online). It was found that nafcillin and cefalotin stimulated spa expression 2-and 3-fold, respectively; however, vancomycin had no effect, a result consistent with diffusion assays. On the other hand, qRT -PCR analyses (as expected) showed no increase in expression of agrB by antibiotics and disc diffusion assays showed that agr RNAIII expression was only weakly affected by sub-MIC antibiotics (Figure 2a ).
Antibiotic interactions
We investigated the effects of combinations of gentamicin plus penicillin G as well as gentamicin plus ciprofloxacin, alone and in combination (Figure 2b ) on transcription of the virulence genes. Antagonistic interactions were observed in the cases of (Figure 2b ). Decreased induction of virulence genes by penicillin G in the presence of gentamicin was observed (Figure 2b) . Combinations of antibiotics are frequently used to treat severe staphylococcal infections. 19 However, because of differences in antibiotic diffusion rates and distribution, not all bacteria are exposed to the required lethal concentrations of bactericidal agents and therefore are likely subjected to sub-MIC antibiotic effects. 3, 6 We employed promoter-lux reporter constructs to analyse antibiotic interactions that might occur under treatment conditions. Three representative S. aureus promoter-lux reporter constructs 20 were studied for their responses to antibiotic combinations. Discs containing antibiotics were placed at specific distances to ensure the inhibition zones were not overlapping, and synergies and antagonisms of antibiotics in the transcription level (light production) were observed. We tested 26 different antibiotic combinations (see Table S2 available as Supplementary data at JAC Online). Representative results of antibiotic interactions are shown in Figure 2c . These findings illustrate an advantage of using lux reporters for studying antibiotic interactions at the transcription level. Figure 1 ). RNAIII down-regulates expression of SarS, a DNA-binding protein that stimulates expression of spa.
11 Furthermore, plasmids carrying spa-lux, lukE-lux and agrP3-lux were transformed into S. aureus RN6390 mutants deficient in SarA (ALC488) or SarS (ALC1927) regulators and antibiotic-induced transcription responses examined.
Subsequent analysis showed that expression of spa and lukE was strongly stimulated by certain b-lactam antibiotics in S. aureus ALC488, but were unaffected in ALC1927 (Figure 2d ). The greater sensitivity of the lux assays could explain the discrepancy with the earlier results of Doss et al., 23 who found that methicillin did not affect protein A production. The expression of agr RNAIII was stimulated by sub-MIC b-lactam antibiotics in both S. aureus ALC488 and ALC1927 ( Figure 2d) ; however, the light response profiles in ALC488 differed from those in S. aureus ALC1927. The different genetic backgrounds of S. aureus (pathogenic strain Newman and laboratory strain RN6390) and the virulence regulators (SarA and SarS) clearly influence the expression of the spa, lukE and agr RNAIII genes in the presence of sub-MIC b-lactam antibiotics (Figure 2a  and d) . The reasons for these differences are not apparent.
Effects of b-lactam antibiotics on biofilm formation
S. aureus is one of the leading causes of implant-associated infections in hospitals. Numerous exogenous and endogenous factors, including the charge and hydrophobicity of the target matrix, adhesins, host proteins, and production of a-toxin facilitate biofilm formation by the pathogen. 24 We tested several b-lactam antibiotics (methicillin, nafcillin, cefalotin and cefoperazone) on S. aureus Newman and its spa and hemB mutants for their effects on biofilm formation. S. aureus Newman and its hemB mutant formed up to 4-and 3-fold denser biofilms, respectively, at 1/3 MIC and 1/4 MIC of cefalotin, while the S. aureus spa knockout mutant formed up to 3-fold denser biofilms at 1/4 MIC of cefalotin (P,0.05). Other antibiotics (methicillin, nafcillin and cefoperazone) had no effect on biofilm formation in the S. aureus strains listed (Figure 3) .
Biofilm formation is one phenotypic measure of virulence expression. Biofilm assay results were different from those of the disc diffusion assays with respect to the effect of sub-MIC cell wall active antibiotics. However, both methods portray strong modulatory effects of sub-MIC cefalotin, which induced virulence genes (spa, lukE and agr RNAIII) in S. aureus Newman (Figure 2a ) and induced biofilm formation in the wild-type, spa mutant and hemB mutant (Figure 3) . These results are in agreement with earlier findings by Haddadin et al., 25 showing that cefalexin, a first-generation cephalosporin similar to cefalotin, stimulates denser biofilm formation over a wide range of antibiotic concentrations. The hemB mutant is a small colony variant known to be resistant to aminoglycosides and b-lactam antibiotics and to produce decreased amounts of exotoxins. 14 The demonstrated stimulation of S. aureus virulence gene expression by sub-MICs of antibiotics could influence the course of disease and compromise antimicrobial therapy. Promoter-lux reporters provide simple and practical tools to study the activities of sub-MICs of antibiotics and their combinations on the expression of different virulence genes. These tools are now available for both Gram-positive and Gramnegative organisms; 16 their use provides novel insights into antibiotic modes of action and they can be employed to reveal favourable therapeutic combinations for the treatment of bacterial infections.
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